Risedronate in resistant Paget's disease of bone
Jelle W. Kylstra, Frederick R. Singer(Saint John's Health Center), A. Valentin-Opran(Unknown), T.L. Clemenst, Pirow Bekker(ChemoCentryx (United States)), Douglas W. Axelrod
Cited by 5
Related Papers
RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 FOR TREATMENT OF OPEN TIBIAL FRACTURES
|Journal of Bone and Joint Surgery|2002|1.3k
Avacopan for the Treatment of ANCA-Associated Vasculitis
|New England Journal of Medicine|2021|957
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
|Journal of the American Society of Nephrology|2017|599
Recombinant Human BMP-2 and Allograft Compared with Autogenous Bone Graft for Reconstruction of Diaphyseal Tibial Fractures with Cortical Defects
|Journal of Bone and Joint Surgery|2006|447
Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.
|Journal of Clinical Investigation|1992|371